01410A: Positional Cloning of Histiocytic Sarcoma (HS) in the Bernese Mountain Dog (BMD) and Flat Coated Retriever (Part A - See also 01410B)

Grant Status: Closed

Grant Amount: $50,000
Elaine A Ostrander, PhD; National Human Genome Research Institute
January 1, 2011 - December 31, 2011

Sponsor(s): American Bouvier des Flandres Club - Bouvier Health Foundation, American Bullmastiff Association, American German Shepherd Dog Charitable Foundation, Inc., American Miniature Schnauzer Club, Inc., Australian Shepherd Health & Genetics Institute, Australian Terrier International, Briard Club of America Health & Education Trust, Estate of Virginia Lyn Tarquinio, Flat-Coated Retriever Foundation, German Shorthaired Pointer Club of America, Golden Retriever Foundation, Hoffman Miniature Schnauzer Donor Advised Fund, Irish Wolfhound Club of America, Inc., Labrador Retriever Club, Portuguese Water Dog Foundation, Rhodesian Ridgeback Club of the United States, Saluki Health Research, Inc., Staffordshire Bull Terrier Club of America, Starlight Fund, Tibetan Terrier Club of America/Tibetan Terrier Health & Welfare Foundation, United States Australian Shepherd Foundation

Breed(s): Bernese Mountain Dog, Flat-Coated Retriever
Research Program Area: Oncology
Donate to Support this Research Program Area

Project Summary

While rare in the general canine population, histiocytic cancers occur at a high rate in several breeds, most notably Bernese mountain dogs (BMD) and flat-coated retrievers (FCR). We have identified two genomic regions that associate with histiocytic cancer in the BMD and two different regions in the FCR. We propose to identify the specific DNA level mutations that increase susceptibility to histiocytic cancers in both breeds. We will determine how the two regions identified in each breed interact, and identify the changes that likely take place inside the cells that lead to cancer development. We have preliminary evidence for one locus that indicates we are likely to find mutations that affect how genes are regulated rather than changing the proteins produced by the genes. We are designing an assay to determine the function of any regulatory sequences in that region and will apply these methods to the other associated regions as well. We believe that the proposed experiments will lead to the availability of genetic testing, improved diagnostics, and development of new treatments for dogs affected with histiocytic sarcoma.


Abadie, J., Hedan, B., Cadieu, E., De Brito, C., Devauchelle, P., Bourgain, C., … Andre, C. (2009). Epidemiology, Pathology, and Genetics of Histiocytic Sarcoma in the Bernese Mountain Dog Breed. Journal of Heredity, 100(Supplement 1), S19–S27. https://doi.org/10.1093/jhered/esp039
Hedan, B., Thomas, R., Motsinger-Reif, A., Abadie, J., Andre, C., Cullen, J., & Breen, M. (2011). Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior. BMC Cancer, 11(1). https://doi.org/10.1186/1471-2407-11-201
Shearin, A. L., Hedan, B., Cadieu, E., Erich, S. A., Schmidt, E. V., Faden, D. L., … Ostrander, E. A. (2012). The MTAP-CDKN2A Locus Confers Susceptibility to a Naturally Occurring Canine Cancer. Cancer Epidemiology Biomarkers & Prevention, 21(7), 1019–1027. https://doi.org/10.1158/1055-9965.EPI-12-0190-T

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617

Tax ID# 13-3813813


© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.